Fox Run Management, L.L.C. Neogenomics Inc Transaction History
Fox Run Management, L.L.C.
- $433 Million
- Q3 2024
A detailed history of Fox Run Management, L.L.C. transactions in Neogenomics Inc stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 26,468 shares of NEO stock, worth $367,375. This represents 0.09% of its overall portfolio holdings.
Number of Shares
26,468Holding current value
$367,375% of portfolio
0.09%Shares
14 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
125MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$273 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$195 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$95.6 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$91.7 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$90.8 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.75B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...